G/TBT/N/BGD/2  
 
21 February 2019  
(19-1007) Page: 1/2 
Committee on Technical Barriers to Trade  Original: English  
 
  NOTIFICATION  
The following notification is being circulated in accordance with Article 10.6  
 
1. Notifying Member: BANGLADESH   
If applicable, name of local government involved (Article 3.2 and 7.2):   
2. Agency responsible:  
Dr. Khandaker Sagir Ahmed, Director (Current Charge)  
Directorate General of Drug Administration.  
Aushad Bhavan, Mohakhali  
Dhaka -1212, Bangladesh  
Tel: 8802 9880841, 9880864, 9880897, 9880924  
Mobile: 008801708506004  
Fax : 8802 9880854  
Email dgda.gov.bd@gmail.com   
Name and address (including telephone and fax numbers, email and website 
addresses, if available) of agency or authority designated to handle comments 
regarding the notification shall be indicated if different from above:   
3. Notified under Article 2.9.2 [X], 2.10.1 [   ], 5.6.2 [   ], 5.7.1 [   ], other:  
4. Products covered (HS or CCCN where applicable, otherwise national tariff 
heading. ICS numbers may be provide d in addition, where applicable): Medicine 
and pharmaceutical products  
5. Title, number of pages and language(s) of the notified document: The National 
Drug Policy 2016 (27 page(s), in English)    
6. Description of content: The Policy is aimed at:  
• Availability to efficacious, safe and quality drugs  
• Rational and safe use of drugs;  
• Drug registration  
• Registration for import  
• Production of drugs and raw materials  
• Prevention of production, sale & distribution of fake, adulterated, substandard 
drugs  
• Drug selection, quantity fixation. Drug procurement, storage and distribution 
processes  
• Control of drug advertising and promotion  
• New technology and technical knowledge transfer in Country  
• Joint collaborative research and development of drugs  G/TBT/N/BGD/2  
 
- 2 - 
 
  • Effective Monitori ng of Pharmacovigilance or Adverse Drug Reactions (ADR)  
• Incentives for drug export  
7. Objective and rationale, including the nature of urgent problems where 
applicable: The Policy aims:  
• to ensure that the people have easy access to safe, effective and good quality 
drugs at affordable prices  
• to ensure rational and safe use of drugs and proper dispensing  
• to achieve self -sufficiency in the manufacture of drugs and raw materials by 
providing services and facilities on a priority basis to all local drug manu facturing 
industries  
• to expand the export of drugs that are manufactured in the country  
• to establish effective surveillance system of medicines.  
8. Relevant documents:   
• Drug Control Ordinance 1982 (Available in English)  
http://www.dgda.gov.bd/index.php/laws -and-policies/117 -drug-control -ordinance -
1982-1 
• Drug Control Ordinance 2006 (Available in Bengali)  
• Amended Drug Rules 1945 (Available in English)  
• Drug Rules 1946 (Available in English)  
http://www.dgda.gov.bd/index.php/l aws-and-policies/83 -drug-act-1940 
9. Proposed date of adoption: 17 March 2017  
Proposed date of entry into force: 17 March 2017  
10. Final date for comments: Not applicable  
11. Texts available from: National enquiry point [  ] or address, telephone and fax 
numbers and email and website addresses, if available, of other body:   
Dr. Khandaker Sagir Ahmed  
Director (Current Charge)  
Directorate General of Drug Administration.  
Aushad Bhavan, Mohakhali, Dhaka -1212, Bangladesh  
Tel : 8802 9880841, 9880864, 9880897, 9880924  
Mobile: 008801708506004,  
Fax : 8802 9880854, E -mail dgda.gov.bd@gmail.com  
http://www.dgda.gov.bd/index.php/laws -and-policies/261 -national -drug-policy -2016-
english -versio n